Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4YV | ISIN: CNE100000411 | Ticker-Symbol: XIN
Frankfurt
06.06.25 | 08:05
0,645 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,6550,71517:33

Aktuelle News zur SHANDONG XINHUA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON ICOSAPENT ETHYL SOFT CAPSULES HAVING OBTAINED DRUG REGISTRATION CERTIFICATE-
DoSHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON ISAVUCONAZONIUM SULFATE FOR INJECTION HAVING OBTAINED DRUG REGISTRATION CERTIFICATE1
22.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON IBUPROFEN SUSPENSION DROPS HAVING OBTAINED DRUG REGISTRATION CERTIFICATE-
19.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON ICOSAPENT ETHYL HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF MARKETING APPLICATION ...-
14.05.SHANDONG XINHUA (00719): REPLY SLIP FOR 2024 ANNUAL GENERAL MEETING1
14.05.SHANDONG XINHUA (00719): PROXY FORM FOR 2024 ANNUAL GENERAL MEETING1
14.05.SHANDONG XINHUA (00719): NOTICE OF THE ANNUAL GENERAL MEETING3
14.05.SHANDONG XINHUA (00719): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF THE ANNUAL GENERAL MEETING2
SHANDONG XINHUA PHARMACEUTICAL Aktie jetzt für 0€ handeln
09.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG APPLICATION ...-
28.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG APPLICATION ...-
28.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON NEW SPECIFICATIONS OF ASPIRIN ENTERIC-COATED TABLETS PASSING THE GENERICS DRUGS ...-
28.04.SHANDONG XINHUA (00719): REMINDER LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
28.04.SHANDONG XINHUA (00719): REMINDER LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
28.04.SHANDONG XINHUA (00719): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT-
28.04.SHANDONG XINHUA (00719): 2024 ANNUAL REPORT-
28.04.SHANDONG XINHUA (00719): UNAUDITED FIRST QUARTER RESULTS OF 20252
23.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON MEMANTINE HYDROCHLORIDE ORAL SOLUTION HAVING OBTAINED THE DRUG REGISTRATION ...-
23.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON PREGABALIN ORAL SOLUTION HAVING OBTAINED DRUG REGISTRATION CERTIFICATE-
14.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG APPLICATION ...1
14.04.SHANDONG XINHUA (00719): ANNOUNCEMENT NOTICE OF BOARD MEETING1
Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1